Wordt geladen...
Development of Novel Radiosensitizers through the National Cancer Institute’s Small Business Innovation Research Program
While radiosensitizing chemotherapy has improved survival for several types of cancer, current chemoradiation regimens remain ineffective for many patients and have substantial toxicities. Given the strong need for the development of novel radiosensitizers to further improve patient outcomes, the Ra...
Bewaard in:
| Gepubliceerd in: | Radiat Res |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7266046/ https://ncbi.nlm.nih.gov/pubmed/32216707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1667/RR15545.1 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|